Ensuring Compliance: A Practical Guide for Australian Veterinary Professionals
Prescribing off-label CBD Treatments
1. Introduction: Navigating the New Frontier of Cannabinoid Medicine
The therapeutic application of cannabidiol (CBD) in veterinary medicine represents one of the most significant shifts in companion animal care in recent years. As client demand grows and clinical evidence accumulates, Australian veterinarians are increasingly considering off-label prescribing of CBD products to manage a range of challenging conditions. However, this promising therapeutic avenue is accompanied by a complex regulatory landscape that requires careful navigation to ensure full compliance.
This guide is designed to provide Australian veterinary professionals with a clear, step-by-step framework for the compliant off-label prescription of HEMP DROPS™, a full-spectrum, Australian-grown hemp supplement. While not registered as a veterinary medicine, HEMP DROPS™ can be used off-label in a manner compliant with Schedule 4 (S4) requirements when appropriate professional protocols are followed. This document clarifies these protocols, empowering veterinarians to confidently integrate this valuable tool into their practice while upholding the highest standards of professional conduct and patient care.
2. The Compliant Prescribing Pathway: A Step-by-Step Protocol
State and Territory Veterinary Professional Boards (VPBs) permit veterinarians to exercise professional judgement in the 'off-label' use of most drugs and veterinary medicines. To do so responsibly with a product like HEMP DROPS™, a structured and well-documented approach is essential. The following pathway outlines the key steps to ensure compliance and best practice.
2.1 Establishing a Veterinarian-Client-Patient Relationship (VCPR)
The foundation of any prescription, particularly an off-label one, is a valid VCPR. This requires the veterinarian to have assumed responsibility for making medical judgments regarding the health of the animal and the need for medical treatment, and the client has agreed to follow the veterinarian's instructions. The veterinarian must have sufficient knowledge of the animal to initiate at least a general or preliminary diagnosis, which is typically achieved through a recent physical examination.
2.2 Clinical Justification and Rationale
Off-label use should be considered when an approved, registered veterinary medicine is unavailable, unsuitable, or has been found to be ineffective for the specific patient. The veterinarian must establish a sound clinical justification for choosing a CBD product. This rationale should be clearly documented in the patient's medical records, detailing the condition being treated (e.g., refractory osteoarthritis pain, multifactorial anxiety, palliative care) and the reasons why conventional therapies are not appropriate or sufficient.
2.3 Obtaining Informed Consent
Given the off-label status of HEMP DROPS™, obtaining and documenting informed consent from the client is a critical step. The discussion should cover:
- The off-label nature of the treatment.
- The potential benefits based on current evidence and clinical experience.
- Potential side effects (e.g., mild sedation, gastrointestinal upset) and what to monitor for.
- The proposed treatment plan, including dosage, administration, and follow-up schedule.
- The costs associated with the treatment.
A signed consent form is highly recommended to formalise this process.
2.4 Prescribing, Dispensing, and Secure Handling
When prescribed off-label, HEMP DROPS™ should be handled with the same diligence as a Schedule 4 medication. This includes:
- Secure Storage: The product should be stored securely within the clinic, accessible only to authorised veterinary staff, to prevent diversion or misuse.
- Accurate Labeling: The dispensed product must be labeled in accordance with state and territory regulations for prescribed medicines. This typically includes the clinic's details, patient and client name, date of dispensing, the name of the product ("HEMP DROPS™ Full-Spectrum Hemp Concentrate"), clear dosage instructions, and cautionary statements such as "For animal treatment only" and "Keep out of reach of children."
- Meticulous Record-Keeping: All prescriptions and dispensations must be recorded in the patient's medical file and, where required, in a drug register, just as with any S4 drug. This creates an auditable trail of the veterinarian's decision-making and dispensing process.
2.5 Patient Monitoring and Follow-up
Effective management involves ongoing monitoring of the patient's response to treatment. Schedule regular follow-up appointments or calls to assess efficacy, monitor for adverse effects, and make dosage adjustments as needed. This not only ensures optimal patient outcomes but also reinforces the VCPR and demonstrates a high standard of care.
3. Why Drops? The Clinical Rationale for HEMP DROPS™
HEMP DROPS™ are formulated as an oral liquid concentrate, a delivery method that offers distinct advantages in a clinical setting.
3.1 The Advantage of Full-Spectrum Formulations
HEMP DROPS™ are a full-spectrum, whole-plant hemp concentrate, which is a critical point of distinction from CBD isolates [4]. Emerging science strongly supports the concept of the "entourage effect," where the therapeutic efficacy of the cannabis plant is greater when its full profile of compounds works in synergy [2]. A whole-plant extract contains not only CBD but also hundreds of other components, including:
- Minor Cannabinoids: Compounds like Cannabigerol (CBG), Cannabinol (CBN), and Cannabichromene (CBC) have their own potential medicinal properties that complement CBD [2].
- Terpenes: These aromatic compounds (e.g., Limonene, Pinene) are not only responsible for the plant's scent but also possess therapeutic benefits, including anti-inflammatory, antibacterial, and anti-anxiety properties [2].
- Flavonoids: Plant compounds like Quercetin and Cannflavins contribute antioxidant and anti-inflammatory effects, with some, like Quercetin, being noted for their potential to modulate allergic responses [2].
This complex interplay of compounds is believed to provide a broader and more effective therapeutic outcome than a single, isolated molecule, leading to better clinical results and higher client satisfaction.
3.2 Clinical Validation: A Veterinarian's Perspective
The successful integration of CBD into veterinary practice is best illustrated by the real-world experience of clinicians. Dr. Kelly Halls of Bentons Road Veterinary Clinic, an integrative practice on the Mornington Peninsula, has been prescribing HEMP DROPS™ for several years and provides compelling validation of their efficacy and safety [1].
Dr. Halls identifies four primary indications where she finds CBD oil particularly useful: osteoarthritis, skin allergies/irritations, inflammatory bowel conditions, and anxiety. Her clinical experience highlights two key scenarios that validate the use of drops:
1. As a Safe Alternative When Conventional Medications are Contraindicated: A significant advantage of CBD is its high safety profile. Dr. Halls provides a powerful example of treating a dog with osteoarthritis that also has kidney disease. In this case, conventional non-steroidal anti-inflammatory drugs (NSAIDs) would be contraindicated. She states: "CBD has the beautiful benefit of treating the osteoarthritis pain, but also being supportive to the kidneys and not causing further damage." [1] This ability to provide pain relief without compromising organ function fills a critical gap in veterinary therapeutics. Dr. Halls further emphasizes its safety, noting that CBD "doesn't actually have an LD50" (a known lethal dose) and that the most common side effect of an excessive dose is merely mild sleepiness [1].
2. As an Effective Adjunctive or Multi-Modal Therapy: Dr. Halls frequently uses CBD drops in combination with other medications. This can be to provide additional pain relief in senior or palliative care patients already on a multi-drug regimen, or to simplify treatment for animals with multiple concurrent conditions. For a patient with arthritis, skin issues, and anxiety, CBD can address all three, potentially reducing the overall medication burden [1].
The success of this approach is demonstrated in her case studies. In one case, a highly reactive Cattle Dog named Pepper, who had failed to respond to multiple conventional anxiety medications or lost her personality on them, found her "sweet spot" with a combination of low-dose CBD and Fluoxetine. She retained her personality while becoming less reactive [1]. In another, more complex case, a Weimaraner named Roman with a severe, life-threatening immunodeficiency syndrome was stabilized using a combination approach that included CBD oil. The treatment resulted in normalized body temperature, hair regrowth, weight gain, and a settled demeanor, dramatically improving his quality of life [1].
These clinical experiences provide strong, practice-based evidence validating the use of CBD drops as a versatile, safe, and effective tool in the modern veterinary clinic.
To hear more from Dr. Kelly Halls about her clinical experience, you can watch her full interview here: https://www.youtube.com/watch?v=koFZYHYZdLw
4. Conclusion: A Compliant and Confident Approach
Prescribing off-label CBD treatments offers a significant opportunity to improve patient welfare, especially for those with chronic or complex conditions. By adhering to a structured, documented pathway—encompassing a valid VCPR, clear clinical justification, informed consent, and meticulous S4-equivalent handling—veterinarians can confidently and compliantly integrate HEMP DROPS™ into their practice. The clinical validation provided by experienced veterinarians like Dr. Kelly Halls, combined with the therapeutic advantages of a full-spectrum formulation, underscores the value of this modality. Partnering with a reputable supplier like HEMP PET ensures access to a consistent, high-quality product and the resources needed for seamless and professional integration.
Disclaimer: This document is intended as a practical guide for registered veterinary professionals in Australia. All practitioners must understand and comply with the laws, regulations, and standards of care of their appropriate jurisdiction. This guide does not constitute legal advice.
References
1. Halls, K. (n.d.). Dr Kelly Halls HempPet Hemp Drops Interview. YouTube. Retrieved January 23, 2026, https://www.youtube.com/watch?v=koFZYHYZdLw
2. Jones, A. (2025). What Science Now Says About Cannabis for Dogs & Cats (2025 Update). Based on a presentation by Dr. Trina Hazzah at the Feed Real Pet Summit. https://www.youtube.com/watch?v=AfnzUKuubWI
3. D. Boothe, DVM, PhD, DACVIM, DACVCP, Veterinary Partner, Cannabidiol Use in Dogs and Cats
https://veterinarypartner.vin.com/default.aspx?pid=19239&catId=225989&id=11754354
4. Blaskovich et al. (2021). The Antimicrobial Potential of Cannabidiol. Communications Biology, 4:7. https://pmc.ncbi.nlm.nih.gov/articles/PMC7815910/